Khiron Life Sciences Conducts Bought Deal Financing For Gross Proceeds Of $10.0 Million

Khiron Life Sciences (TSXV: KHRN) announced that it is conducting at $10.0 bought deal private placement this morning. Lead by Canaccord Genuity, the financing will see units of the company sold at a price of $0.45 per unit.

A total of 22,250,000 units of the company are expected to be sold under the bought deal financing, with each unit comprising of one common share and one common share purchase warrant. Each warrant is valid for a period of five years, with an exercise price of $0.75 per share. A 15% over allotment option also exists on the financing for a period of 30 days, which if exercised would bring the total raise to $11.5 million.

Proceeds from the financing are to be used to expand the operating capacity of the company as well as for working capital and general corporate purposes. The financing is currently anticipated to be closed by November 26, 2020.

Khiron Life Sciences last traded at $0.55 on the TSX Venture.


FULL DISCLOSURE: Khiron Life Sciences is a former client of Canacom Group, the parent company of The Deep Dive. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Khiron Life Sciences Records $2.8 Million In Revenue, $4.8 Million Net Loss In Q2 2021

Khiron Life Sciences Corp. (TSXV: KHRN) reported this morning its financial statements for the quarter...

Monday, August 23, 2021, 09:30:00 AM

Khiron Imports First Product To UK, Receives First European Prescriptions

Khiron Life Sciences (TSXV: KHRN) has officially entered the United Kingdom’s medical cannabis market, announcing...

Wednesday, May 6, 2020, 08:34:00 AM

Khiron Signs Exclusive Partnership with Rappi, The Amazon Of South America

Khiron Life Sciences (TSXV: KHRN) this morning announced the significant development of establishing an exclusive...

Friday, September 4, 2020, 08:17:02 AM

Khiron Life Sciences To Conduct Share Buybacks

Khiron Life Sciences (TSXV: KHRN) announced this morning that it will be conducting a normal...

Tuesday, February 11, 2020, 09:20:58 AM

Khiron Receives Authorization For Sale Of High-THC Medical Cannabis

Khiron Life Sciences (TSXV: KHRN) announced this morning that it has received authorization from the...

Wednesday, May 20, 2020, 08:47:31 AM